Search Results - Santafe, D. Llige

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    P2.03-45 PKCι-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant Adenocarcinoma and Squamous Cell Carcinoma

    P2.03-45 PKCι-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant Adenocarcinoma and Squamous Cell Carcinoma by Ito, M., Codony-Servat, C., Codony-Servat, J., Santafe, D. Llige, Chaib, I., Cai, X., Cao, P., Bracht, J., Okada, M., Karachaliou, N., Rosell, R.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P1.03-14 HLA-E and FAT1 in Head and Neck and Lung Cancer. The Effect of Osimertinib or Olmutinib with Artesunate (Dihydroartemisinin)

    P1.03-14 HLA-E and FAT1 in Head and Neck and Lung Cancer. The Effect of Osimertinib or Olmutinib with Artesunate (Dihydroartemisinin) by Chaib, I., Rosell, R., Cao, P., Karachaliou, N., Cai, X., Hermsen, M., Santafe, D. Llige, Santarpia, M., Gonzalez-Cao, M., Cecere, F., Filipska, M., Pedraz, C., Bracht, J., Ito, M., Hernandez, A. Aguilar, Codony-Servat, J., Cardona, A.F.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: